StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) KPIs and segments

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BioAge Labs's business

Coming soon

This tab will track the numbers specific to BioAge Labs's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?